TGTGInsighttelegram intelligenceLIVE / telegram public index
← GitHub Trends

TGINSIGHT SIMILAR POSTS

Find similar content

Source channel @githubtrending · Post #15421 · Jan 18

#python#audio#deeplearning#minicpm#python#pytorch#speech#speech_synthesis#text_to_speech#tts#tts_model#voice_cloning VoxCPM is a free, open-source TTS tool that turns text into realistic speech without tokens, creating expressive audio that matches context and clones voices perfectly from just 3-10 seconds of sample. Download VoxCPM1.5 (800M params) from Hugging Face, install via pip, and use simple Python or CLI commands for fast synthesis (RTF 0.15 on RTX 4090) or fine-tuning your own voices. You benefit by easily making natural audiobooks, podcasts, clones, or apps with pro-quality sound—saving time and costs on voice work. https://github.com/OpenBMB/VoxCPM

Results

2 similar posts found

Search: #molnupiravir

当前筛选 #molnupiravir清除筛选
ÉTIENNE CHOUARD

@chouard · Post #229 · 10/26/2021, 08:48 PM

Donc quand 2 grands fabricants de médicaments génériques en #Inde stoppent leur essai du #Molnupiravir de #Merck, parce qu'il ne marche pas sur les #Covid19 modérés... Olivier #Véran en commande 50.000 doses. 😅 D'ailleurs Merck a arrêté lui-même son essai sur les patients #Covid hospitalisés (pour tester en outpatients)... La boussole sud quoi https://www.reuters.com/business/healthcare-pharmaceuticals/aurobindo-pharma-stop-molnupiravir-trial-moderate-covid-19-patients-2021-10-08/https://www.businesswire.com/news/home/20210415005258/en/https://www.lavoixdunord.fr/1090028/article/2021-10-26/c-est-quoi-le-molnupiravir-medicament-anti-covid-dont-la-france-commande-50-000

香港抗疫資訊頻道

@HKFIGHTCOVID19 · Post #4759 · 03/15/2022, 11:22 PM

【新冠口服藥處方應用💊】政府已根據專家意見,通過醫管局採購合適數量的新冠口服抗病毒藥物,其中默沙東藥廠的莫納皮拉韋(Molnupiravir)已全數抵港並正在應用,另一款輝瑞藥廠的帕克斯洛維德(Paxlovid)首批昨日(3月14日)亦已抵港,其他批次未來兩三個月會陸續到港👏🏻👏🏻。 醫生會按臨牀指引📃和病人情況處方藥物給以下合適病人😷: 📍公立醫院住院病人 📍指定診所社區確診者 📍安老院舍確診患者 📍私家醫院新冠病人 臨床研究結果顯示,新冠口服藥有機會減低有高危因素患者的住院及死亡風險🙏🏻。我們會繼續購買及儲備相關藥物💪🏻💪🏻。 新聞公報:https://bit.ly/3tbeim6 #同心抗疫#2019冠狀病毒病#新冠口服抗病毒藥物#默沙東#莫納皮拉韋#Molnupiravir#輝瑞#帕克斯洛維德#Paxlovid#臨牀指引#新冠病人#減住院及死亡風險#全民同心抗疫